Viewing Study NCT03448393


Ignite Creation Date: 2025-12-25 @ 1:09 AM
Ignite Modification Date: 2025-12-25 @ 11:20 PM
Study NCT ID: NCT03448393
Status: COMPLETED
Last Update Posted: 2025-06-04
First Post: 2018-02-27
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies
Sponsor: National Cancer Institute (NCI)
Organization: